It may be an article of faith among geneticists that knowledge is power in cases like Gessen's, but she reminds us that it is also terror: More than eight years after testing for the Huntington's mutation was available, only 300 people in the United States completed the screening process.
Sixty-six percent (239/360) of the clinic patients completed the screening: About 72.4% (173/239) (95% confidence interval [CI] = 66.7%, 78.1%) were positive for BPD on the Structured Clinical Interview for DSM-IV Personality Disorders Patient Questionnaire (SCID-II-PQ), and 22.6% (54/239) (95% CI = 17.3%, 27.9%) were positive for BPD on the DIB-R.
Two hundred thirty applicants completed the screening questionnaires and underwent the interview.
Of these, 2331 (41.6%) enrolled and completed the screening protocol; the remainder refused participation.
In the primary care sub-cohort using culture and DFA, 271 patients completed the screening questionnaire but only 58 (21%) underwent microbiologic assessment.
We have now completed the screening of this new kit with four different RPTP-AP fusion proteins, corresponding to the XC domains of Lar, Ptp10D, Ptp69D, and Ptp99A.
In total, 5,500 completed the screening.
50 persons registered and completed the screening.
At baseline, 13,004 participants completed the screening interview.
A total of 10,384 adults (94.3%) completed the screening.
